|
POLR2C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.860000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.341500E-03 |
| Normal-vs-Stage2 |
6.368000E-01 |
| Normal-vs-Stage3 |
2.423000E-03 |
| Normal-vs-Stage4 |
9.456800E-03 |
| Stage1-vs-Stage2 |
1.355450E-01 |
| Stage1-vs-Stage3 |
3.958400E-01 |
| Stage1-vs-Stage4 |
7.049400E-01 |
| Stage2-vs-Stage3 |
6.506200E-02 |
| Stage2-vs-Stage4 |
1.227040E-01 |
| Stage3-vs-Stage4 |
8.060400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.276500E-03 |
| Normal-vs-AfricanAmerican |
5.674200E-01 |
| Normal-vs-Asian |
4.757700E-02 |
| Caucasian-vs-AfricanAmerican |
1.524200E-01 |
| Caucasian-vs-Asian |
5.001200E-01 |
| AfricanAmerican-vs-Asian |
3.821800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.380520E-03 |
| Normal-vs-Female |
2.056100E-02 |
| Male-vs-Female |
1.387420E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.795100E-03 |
| Normal-vs-Age(41-60Yrs) |
9.995100E-03 |
| Normal-vs-Age(61-80Yrs) |
2.399900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.005400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.291600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.785800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.669400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.831000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.703600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.545600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.024410E-01 |
| Classical-VS-Follicular |
8.630000E-01 |
| Classical-VS-Other |
7.526600E-01 |
| Classical-VS-Normal |
1.726110E-02 |
| Tall-VS-Follicular |
1.827200E-01 |
| Tall-VS-Other |
6.260000E-01 |
| Tall-VS-Normal |
1.375630E-03 |
| Follicular-VS-Other |
8.499000E-01 |
| Follicular-VS-Normal |
3.862200E-02 |
| Other-VS-Normal |
1.937200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.224040E-02 |
| Normal-vs-N1 |
3.72440000000474E-05 |
| N0-vs-N1 |
1.615980E-02 |
|
|
